Hyper-Progressive Disease on Immunotherapy in Advanced NSCLC (BMIC-012)
Oct 27, 2017•8 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Jack West reviews evidence that a subset of patients with advanced NSCLC demonstrate "hyper-progressing disease" (HPD), worsening cancer at a faster rate, on immune checkpoint inhibitor therapy, more commonly than seen in patients on chemotherapy.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast